EyePoint Pharmaceuticals Inc (NASDAQ:EYPT)
| 10.53 Delayed Data As of 4:00pm ET |  -0.94 / -8.20%Today’s Change | 3.51 Today|||52-Week Range 15.06 | +60.03% Year-to-Date |
Institutional investors hold a majority ownership of EYPT through the 57.99% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended June 2019, these large investors purchased a net $2.2 million shares.
| Other institutional | 33.80% |
| Mutual fund holders | 24.19% |
| Individual stakeholders | 11.01% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 6/30/2021 | BLACKROCK FUND ADVISORS Bought 1.0 Million shares of EyePoint Pharmaceuticals ... |
| 8/03/2021 | RA CAPITAL MANAGEMENT LP Bought 356.9 Thousand shares of EyePoint Pharmaceuticals ... |
| 6/30/2021 | SSGA FUNDS MANAGEMENT, INC. Bought 226.6 Thousand shares of EyePoint Pharmaceuticals ... |
Top 10 Owners of EyePoint Pharmaceuticals Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Franklin Advisers, Inc. | 9.67% | 2,781,619 | 30,430,912 | -89,528 | -3.12% |
| RA Capital Management LP | 5.59% | 1,606,859 | 17,579,037 | +356,859 | +28.55% |
| Adage Capital Management LP | 5.56% | 1,600,000 | 17,504,000 | +81,789 | +5.39% |
| Suvretta Capital Management LLC | 5.55% | 1,595,164 | 17,451,094 | +216,832 | +15.73% |
| The Vanguard Group, Inc. | 3.71% | 1,066,221 | 11,664,458 | +172,629 | +19.32% |
| BlackRock Fund Advisors | 3.51% | 1,010,157 | 11,051,118 | +1,007,849 | +43,667.63% |
| Citadel Advisors LLC | 3.33% | 957,885 | 10,479,262 | -77,719 | -7.50% |
| Driehaus Capital Management LLC | 2.64% | 758,423 | 8,297,148 | -52,393 | -6.46% |
| Janus Capital Management LLC | 2.31% | 664,498 | 7,269,608 | -8,887 | -1.32% |
| HighTower Advisors LLC | 1.84% | 528,428 | 5,781,002 | -40 | -0.01% |
Top 10 Mutual Funds Holding EyePoint Pharmaceuticals Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| FTIF SICAV - Biotechnology Discov... | 4.88% | 1,404,120 | 15,361,073 | +242,200 | +20.84% |
| Franklin Biotechnology Discovery ... | 2.91% | 836,730 | 9,153,826 | 0 | 0.00% |
| Franklin Small Cap Growth Fund | 2.61% | 750,000 | 8,205,000 | 0 | 0.00% |
| Vanguard Total Stock Market Index... | 2.44% | 702,533 | 7,685,711 | 0 | 0.00% |
| Highland Fds. I - Long/Short Heal... | 1.89% | 545,000 | 5,962,300 | +490,500 | +900.00% |
| iShares Russell 2000 ETF | 1.68% | 483,344 | 5,287,783 | +2,160 | +0.45% |
| Vanguard Extended Market Index Fu... | 0.93% | 268,616 | 2,938,659 | 0 | 0.00% |
| Heptagon Fund Plc - Driehaus US M... | 0.91% | 262,550 | 2,872,297 | 0 | 0.00% |
| iShares Russell 2000 Value ETF | 0.75% | 215,609 | 2,358,762 | -784 | -0.36% |
| Xtrackers - S&P 500 Swap UCITS ET... | 0.71% | 203,042 | 2,221,279 | 0 | 0.00% |